RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Stratos Wealth Partners, LTD.'s Holding History (CIK: 0001612865)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 116,434 Value ($000) $476 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 110,611 Value ($000) $540 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 98,704 Value ($000) $499 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 11,974 Value ($000) $63 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 16,553 Value ($000) $112 Avg Close $6.72 Range $5.60 - $9.55

Q1 2024

Shares 13,436 Value ($000) $134 Avg Close $11.14 Range $8.68 - $15.74

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	116,434	$476	$4.95	$3.81 - $7.18
Q3 2025	110,611	$540	$5.25	$4.45 - $7.15
Q2 2025	98,704	$499	$4.91	$3.79 - $6.11
Q1 2025	11,974	$63	$7.29	$5.19 - $12.36
Q4 2024	16,553	$112	$6.72	$5.60 - $9.55
Q1 2024	13,436	$134	$11.14	$8.68 - $15.74